202 related articles for article (PubMed ID: 30075316)
1. Identification and characterization of in vitro inhibitors against UDP-glucuronosyltransferase 1A1 in uva-ursi extracts and evaluation of in vivo uva-ursi-drug interactions.
Park JB; Kim D; Min JS; Jeong S; Cho DY; Zheng YF; Yoon KD; Bae SK
Food Chem Toxicol; 2018 Oct; 120():651-661. PubMed ID: 30075316
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.
Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK
Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066
[TBL] [Abstract][Full Text] [Related]
3. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions.
Zheng YF; Min JS; Kim D; Park JB; Choi SW; Lee ES; Na K; Bae SK
Molecules; 2016 Aug; 21(8):. PubMed ID: 27529203
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of uva-ursi against cytochrome P450 isoenzymes and P-glycoprotein.
Chauhan B; Yu C; Krantis A; Scott I; Arnason JT; Marles RJ; Foster BC
Can J Physiol Pharmacol; 2007 Nov; 85(11):1099-107. PubMed ID: 18066112
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the in vitro/in vivo potential of five berries (bilberry, blueberry, cranberry, elderberry, and raspberry ketones) commonly used as herbal supplements to inhibit uridine diphospho-glucuronosyltransferase.
Choi EJ; Park JB; Yoon KD; Bae SK
Food Chem Toxicol; 2014 Oct; 72():13-9. PubMed ID: 24997313
[TBL] [Abstract][Full Text] [Related]
7. [Anti-tyrosinase activity constituents of Arctostaphylos uva-ursi].
Matsuo K; Kobayashi M; Takuno Y; Kuwajima H; Ito H; Yoshida T
Yakugaku Zasshi; 1997 Dec; 117(12):1028-32. PubMed ID: 9437910
[No Abstract] [Full Text] [Related]
8. Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells.
Sun H; Zhou X; Wu B
Xenobiotica; 2015; 45(11):945-53. PubMed ID: 26068529
[TBL] [Abstract][Full Text] [Related]
9. Structure-inhibition relationship of podophyllotoxin (PT) analogues towards UDP-glucuronosyltransferase (UGT) isoforms.
Qi JQ; Cao YF; Sun XY; Hong M; Fang ZZ; Meng DL; Sun DX
Pharmazie; 2015 Apr; 70(4):239-43. PubMed ID: 26012253
[TBL] [Abstract][Full Text] [Related]
10. Pazopanib interacts with irinotecan by inhibiting UGT1A1-mediated glucuronidation, but not OATP1B1-mediated hepatic uptake, of an active metabolite SN-38.
Iwase M; Fujita KI; Nishimura Y; Seba N; Masuo Y; Ishida H; Kato Y; Kiuchi Y
Cancer Chemother Pharmacol; 2019 May; 83(5):993-998. PubMed ID: 30810774
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the drug-drug interactions potential of erlotinib and gefitinib via inhibition of UDP-glucuronosyltransferases.
Liu Y; Ramírez J; House L; Ratain MJ
Drug Metab Dispos; 2010 Jan; 38(1):32-9. PubMed ID: 19850672
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of naturally occurring inhibitors against UDP-glucuronosyltransferase 1A1 in Fructus Psoraleae (Bu-gu-zhi).
Wang XX; Lv X; Li SY; Hou J; Ning J; Wang JY; Cao YF; Ge GB; Guo B; Yang L
Toxicol Appl Pharmacol; 2015 Nov; 289(1):70-8. PubMed ID: 26348140
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of the structure-activity relationships involved in UGT1A1 inhibition by anthraquinone and dianthrone constituents of Polygonum multiflorum.
Wang Q; Wang Y; Li Y; Wen B; Dai Z; Ma S; Zhang Y
Sci Rep; 2017 Dec; 7(1):17952. PubMed ID: 29263357
[TBL] [Abstract][Full Text] [Related]
14. In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.
Lee SJ; Park JB; Kim D; Bae SH; Chin YW; Oh E; Bae SK
Toxicol Lett; 2015 Jan; 232(2):458-65. PubMed ID: 25448279
[TBL] [Abstract][Full Text] [Related]
15. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
[TBL] [Abstract][Full Text] [Related]
16. Identification of Intestinal UDP-Glucuronosyltransferase Inhibitors in Green Tea (
Tian DD; Kellogg JJ; Okut N; Oberlies NH; Cech NB; Shen DD; McCune JS; Paine MF
Drug Metab Dispos; 2018 May; 46(5):552-560. PubMed ID: 29467215
[TBL] [Abstract][Full Text] [Related]
17. Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10.
Ramírez J; Mirkov S; House LK; Ratain MJ
Drug Metab Dispos; 2015 Jul; 43(7):928-35. PubMed ID: 25870101
[TBL] [Abstract][Full Text] [Related]
18. UHPLC-PDA-ESI-TOF/MS metabolic profiling of Arctostaphylos pungens and Arctostaphylos uva-ursi. A comparative study of phenolic compounds from leaf methanolic extracts.
Panusa A; Petrucci R; Marrosu G; Multari G; Gallo FR
Phytochemistry; 2015 Jul; 115():79-88. PubMed ID: 25702282
[TBL] [Abstract][Full Text] [Related]
19. Characterization of N-glucuronidation of 4-(5-pyridin-4-yl-1H-[1,2,4]triazol-3-yl) pyridine-2-carbonitrile (FYX-051): a new xanthine oxidoreductase inhibitor.
Omura K; Nakazawa T; Sato T; Iwanaga T; Nagata O
Drug Metab Dispos; 2007 Dec; 35(12):2143-8. PubMed ID: 17761779
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.
Zhang D; Chando TJ; Everett DW; Patten CJ; Dehal SS; Humphreys WG
Drug Metab Dispos; 2005 Nov; 33(11):1729-39. PubMed ID: 16118329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]